Brooklyn Health, a neuroscience company based in Brooklyn, has successfully raised $6.5 million in seed funding, spearheaded by HealthX. The investment aims to expand its artificial intelligence-driven electronic clinical outcome assessment platform, Willis. This innovative platform enhances the precision of clinical trials focused on the central nervous system by automating the quality review of patient interviews, thereby addressing common issues of subjectivity in scoring. Additionally, Willis is supported by the open-source OpenWillis library, which provides tools for digital phenotyping to further enhance mental health assessments.
Brooklyn Health has secured $6.5M in seed funding, led by HealthX, to enhance their AI-driven electronic clinical outcome assessment platform, called Willis.
The Willis platform automates interview quality reviews, resolving subjective scoring issues to improve precision in central nervous system clinical trials.
Collection
[
|
...
]